Monthly Injection Could Free People With Severe Asthma From Steroids By Ernie Mundell HealthDay ReporterMONDAY, Dec. 1, 2025 (HealthDay News) — People with severe asthma often take daily steroid ...
Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...
In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...
Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...
GlobalData on MSN
Fasenra shows benefit in acute asthma and COPD in Phase II trial
A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of ...
Fifteen years ago, former Cincinnati Bengals running back Elbert “Ickey” Woods lost his 16 year old son, Jovante, to an acute asthma attack. Now, he has channeled his grief into action through the ...
NEW YORK (Reuters Health) - Children with asthma may be at increased risk of certain behavioral, emotional and developmental problems, particularly if the asthma is severe, the results of a new study ...
Please provide your email address to receive an email when new articles are posted on . 6.5% of patients with mild asthma had at least one acute exacerbation in the year after the index date.
SAN ANTONIO — For children, a visit to the emergency department for an asthma attack is a red flag for future acute-care visits, and could be used to identify patients who might benefit from ...
Rapid Rx Quiz: Severe Asthma Treatment Are you up-to-date on the latest research on severe asthma treatment, including effective biologics and factors associated with higher asthma biologic adherence?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback